PHARMATHENE

Welcome to the Brand page for “PHARMATHENE”, which is offered here for In the statement, lines 4 through 21 should be deleted, and pharmaceutical preparations for use in biodefense, antibody based pharmaceutical products, monoclonal antibodies, vaccines, pharmaceutical preparations for treatment and prevention of alzheimer's disease, pharmaceutical preparations for treatment and prevention of poisoning, pharmaceutical preparations for treatment and prevention of neurological disease, pharmaceutical preparations for treatment and prevention of infectious disease, recombinant based therapeutics, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations for treatment and prevention of anthrax infection, pharmaceutical preparations for treatment and prevention of toxicity caused by cholinesterase inhibiting compounds, in class 5 should be inserted.;pharmaceutical preparations for use in biodefense, antibody based pharmaceutical products, monoclonal antibodies, vaccines, pharmaceutical preparations for treatment and prevention of alzheimer's disease, pharmaceutical preparations for treatment and prevention of poisoning, pharmaceutical preparations for treatment and prevention of neurological disease, pharmaceutical preparations for treatment and prevention of infectious disease, recombinant based therapeutics, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations for treatment and prevention of anthrax infection, pharmaceutical preparations for treatment and prevention of toxicity caused by cholinesterase inhibiting compounds;pharmaceutical athene;the term pharmathene has no known significance other than as a term coined by the applicant.;.

Its status is currently believed to be active. Its class is unavailable. “PHARMATHENE” is believed to be currently owned by “PharmAthene, Inc.”